Utilisation review of clopidogrel: Are they used under the FDA-approved indications?

Background: Clopidogrel has shown benefit in patients with increased risk of cardiovascular diseases. Due to its high acquisition cost and its increased use, this study was conducted to review the use of clopidogrel based on the Food and Drug Administration (FDA)-approved indications and the ST-segm...

Full description

Saved in:
Bibliographic Details
Main Authors: Surachet Niruntraporn, Nathorn Chaiyakunapruk, Surakit Nathisuwan, Visanu Thamlikitkul
Other Authors: Naresuan University
Format: Review
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/24770
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.24770
record_format dspace
spelling th-mahidol.247702018-08-24T09:01:39Z Utilisation review of clopidogrel: Are they used under the FDA-approved indications? Surachet Niruntraporn Nathorn Chaiyakunapruk Surakit Nathisuwan Visanu Thamlikitkul Naresuan University Mahidol University Medicine Background: Clopidogrel has shown benefit in patients with increased risk of cardiovascular diseases. Due to its high acquisition cost and its increased use, this study was conducted to review the use of clopidogrel based on the Food and Drug Administration (FDA)-approved indications and the ST-segment elevation myocardial infarction (STEMI). Method: This was a cross-sectional study conducted at a tertiary-care, university-affiliated hospital in the Northern part of Thailand. Medical records of patients receiving clopidogrel during January 2005 to February 2006 were reviewed. Baseline characteristics of patients along with specific information regarding the use of clopidogrel were collected. Data were analysed using descriptive statistics. Result: A total of 191 patients were included in this utilisation review (95 and 96 were inpatient and outpatient, respectively). The use of clopidogrel was deemed appropriate in 82.7% of cases including 72.2% for FDA-approved indications and 10.5% for STEMI. Clopidogrel/aspirin combination was indicated in 93 patients; however, 22 patients received clopidogrel monotherapy. On the contrary, 10 patients received clopidogrel/aspirin combination when only clopidogrel monotherapy was indicated. Moreover, 60% of patients who received clopidogrel monotherapy had no history of aspirin intolerance or recurrent events while on aspirin therapy. Conclusion: The results showed that the majority of clopidogrel use was deemed appropriate based on FDA-approved indications and for medically justified indication. However, a significant number of patients received clopidogrel instead of aspirin while no aspirin intolerance was documented. Therefore, efforts should be made to promote the appropriate use of this agent to improve patient outcomes. Copyright © 2007 John Wiley & Sons, Ltd. 2018-08-24T02:01:39Z 2018-08-24T02:01:39Z 2007-09-01 Review Pharmacoepidemiology and Drug Safety. Vol.16, No.9 (2007), 1031-1037 10.1002/pds.1429 10991557 10538569 2-s2.0-34548709759 https://repository.li.mahidol.ac.th/handle/123456789/24770 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34548709759&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
Surachet Niruntraporn
Nathorn Chaiyakunapruk
Surakit Nathisuwan
Visanu Thamlikitkul
Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
description Background: Clopidogrel has shown benefit in patients with increased risk of cardiovascular diseases. Due to its high acquisition cost and its increased use, this study was conducted to review the use of clopidogrel based on the Food and Drug Administration (FDA)-approved indications and the ST-segment elevation myocardial infarction (STEMI). Method: This was a cross-sectional study conducted at a tertiary-care, university-affiliated hospital in the Northern part of Thailand. Medical records of patients receiving clopidogrel during January 2005 to February 2006 were reviewed. Baseline characteristics of patients along with specific information regarding the use of clopidogrel were collected. Data were analysed using descriptive statistics. Result: A total of 191 patients were included in this utilisation review (95 and 96 were inpatient and outpatient, respectively). The use of clopidogrel was deemed appropriate in 82.7% of cases including 72.2% for FDA-approved indications and 10.5% for STEMI. Clopidogrel/aspirin combination was indicated in 93 patients; however, 22 patients received clopidogrel monotherapy. On the contrary, 10 patients received clopidogrel/aspirin combination when only clopidogrel monotherapy was indicated. Moreover, 60% of patients who received clopidogrel monotherapy had no history of aspirin intolerance or recurrent events while on aspirin therapy. Conclusion: The results showed that the majority of clopidogrel use was deemed appropriate based on FDA-approved indications and for medically justified indication. However, a significant number of patients received clopidogrel instead of aspirin while no aspirin intolerance was documented. Therefore, efforts should be made to promote the appropriate use of this agent to improve patient outcomes. Copyright © 2007 John Wiley & Sons, Ltd.
author2 Naresuan University
author_facet Naresuan University
Surachet Niruntraporn
Nathorn Chaiyakunapruk
Surakit Nathisuwan
Visanu Thamlikitkul
format Review
author Surachet Niruntraporn
Nathorn Chaiyakunapruk
Surakit Nathisuwan
Visanu Thamlikitkul
author_sort Surachet Niruntraporn
title Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
title_short Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
title_full Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
title_fullStr Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
title_full_unstemmed Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
title_sort utilisation review of clopidogrel: are they used under the fda-approved indications?
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/24770
_version_ 1763487887754526720